$CLX

Clorox: Fiscal Q1 Earnings Snapshot

Clorox Co. (CLX) reported fiscal Q1 net income of $170M, or $1.39 per share, exceeding analyst expectations of $0.97 per share. Revenue was $1.91B, surpassing forecasts of $1.87B. The company expects full-year earnings of $5.70 to $6 per share.

Original reporting
Published Nov 2, 2026, 11:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 11:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Clorox: Fiscal Q1 Earnings Snapshot — source image
Decision brief

The 30-second read

$CLXBullishHigh
01

Why it matters

The earnings beat and raised guidance are likely to boost investor sentiment and drive short-term price appreciation.

02

Market read

First-quarter earnings beat provides a fresh catalyst for CLX and may influence the consumer staples sector.

03

What to watch

Potential margin pressure from higher input costs not discussed in the release.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Clorox is a leading consumer products company; the report covers its fiscal Q1 performance.

Company-level read

Ticker impact

$CLXBullishHigh confidence
Context

Clorox reported Q1 net income of $170M, EPS $1.39 beating estimates of $0.97 and revenue $1.91B vs $1.87B expectations.

Expected impact

likely upward pressure as the market prices in the earnings beat and higher full-year guidance

Evidence & confidence

Beat on both earnings and revenue, plus raised FY outlook, typically drives short-term price gains.

Market effects

Consumer staples may see modest uplift as a major player beats expectations.

U.S. markets could open higher on the earnings beat.

Limited to U.S. consumer goods sector.

Counterpoint

If the beat is already priced in, the stock could face a pullback.

Key entities

  • Clorox Co.

    Consumer products maker reporting Q1 results.

Related articles

$CLXHighAI 8/10

Clorox’s (NYSE:CLX) Q3 CY2026 sales top estimates

Clorox (NYSE:CLX) reported Q3 CY2026 revenue of $1.91B, up 33.3% YoY and 1.5% above estimates. Adjusted EPS of $1.55 beat estimates by 44.6%. Management reiterated full-year EPS guidance of $5.85 at the midpoint. Organic revenue rose 18% YoY. CEO Linda Rendle cited strong execution and timing benefits but noted higher inflationary pressures. Shares rose 2.1% post-results.

$UPWKMed

Stocks making the biggest moves after hours: Fabrinet, Clorox, Apple, Palantir & more

Upwork shares rose 11% after raising full-year earnings guidance. Palantir's Q3 revenue nearly doubled, surpassing $2B. Lattice Semiconductor's stock jumped 7% on strong Q3 results and raised forecast. Clorox gained 2% with Q1 earnings beating estimates. On Semiconductor fell 2% after announcing a $600M acquisition and Q4 guidance. Apple's Q4 revenue rose 12% to $114.48B, but iPad sales declined. Fabrinet surged 12% on strong Q2 guidance.

$CLXHighAI 8/10

Clorox tops Q1 estimates despite cost pressures, shares rise

Clorox (CLX) reported Q1 adjusted EPS of $1.55, beating estimates by $0.48, with revenue at $1.91B, up 33% YoY. Shares rose 2%. Growth was driven by the GOJO acquisition and last year's inventory adjustments, but higher costs compressed margins. The company maintained FY2027 guidance, expecting EPS near the low end of the range.